• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体作为胆固醇在乳腺癌中病理作用的介质。

The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.

作者信息

McDonnell D P, Chang C-Y, Nelson E R

机构信息

Department of Pharmacology and Cancer Biology, Duke University School of Medicine , Durham, NC , USA.

出版信息

Climacteric. 2014 Dec;17 Suppl 2(0 2):60-5. doi: 10.3109/13697137.2014.966949. Epub 2014 Oct 16.

DOI:10.3109/13697137.2014.966949
PMID:25320023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4332512/
Abstract

Despite increased survivorship among patients, breast cancer remains the most common cancer among women and is the second leading cause of cancer death in women. The magnitude of this problem provides a strong impetus for new chemopreventative strategies and/or lifestyle changes that reduce cancer incidence. It is of significance, therefore, that several studies positively correlate obesity to the development of breast cancer. Importantly, obesity is also highly associated with elevated cholesterol, and cholesterol itself is a risk factor for breast cancer. Furthermore, patients taking statins demonstrate a lower breast cancer incidence and decreased recurrence. The recent observation that 27-hydroxycholesterol (27HC) is produced in a stoichiometric manner from cholesterol, together with our recent demonstration that it exerts partial agonist activity on both the estrogen and liver X receptors, suggested a potential mechanistic link between hyper-cholesterolemia and breast cancer incidence. Using genetic and pharmacological approaches, we have recently shown that elevation of circulating 27HC significantly increases tumor growth and metastasis in murine models of breast cancer. Further, we have demonstrated in appropriate animal models that the impact of high-fat diet on tumor pathogenesis can be mitigated by statins or by small molecule inhibitors of CYP27A1. These findings suggest that pharmacological or dietary modifications that lower total cholesterol, and by inference 27HC, are likely to reduce the impact of obesity/metabolic syndrome on breast cancer incidence.

摘要

尽管患者的生存率有所提高,但乳腺癌仍是女性中最常见的癌症,并且是女性癌症死亡的第二大主要原因。这一问题的严重性为降低癌症发病率的新化学预防策略和/或生活方式改变提供了强大动力。因此,多项研究表明肥胖与乳腺癌的发生呈正相关,这一点具有重要意义。重要的是,肥胖还与胆固醇升高高度相关,而胆固醇本身就是乳腺癌的一个风险因素。此外,服用他汀类药物的患者乳腺癌发病率较低且复发率降低。最近观察到27-羟基胆固醇(27HC)以化学计量方式由胆固醇产生,以及我们最近证明它对雌激素受体和肝脏X受体均具有部分激动剂活性,这提示了高胆固醇血症与乳腺癌发病率之间潜在的机制联系。我们最近使用遗传和药理学方法表明,循环中27HC的升高会显著增加乳腺癌小鼠模型中的肿瘤生长和转移。此外,我们在合适的动物模型中证明,高脂饮食对肿瘤发病机制的影响可通过他汀类药物或CYP27A1小分子抑制剂来减轻。这些发现表明,降低总胆固醇(由此推断也降低27HC)的药理学或饮食调整可能会减少肥胖/代谢综合征对乳腺癌发病率的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95a4/4332512/c27017f14665/nihms-663581-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95a4/4332512/6428e6a23546/nihms-663581-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95a4/4332512/c27017f14665/nihms-663581-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95a4/4332512/6428e6a23546/nihms-663581-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95a4/4332512/c27017f14665/nihms-663581-f0002.jpg

相似文献

1
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.雌激素受体作为胆固醇在乳腺癌中病理作用的介质。
Climacteric. 2014 Dec;17 Suppl 2(0 2):60-5. doi: 10.3109/13697137.2014.966949. Epub 2014 Oct 16.
2
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.27-羟化酶(CYP27A1)和27-羟胆固醇在乳腺癌中的作用
Endocr Relat Cancer. 2017 Jul;24(7):339-349. doi: 10.1530/ERC-16-0533. Epub 2017 Apr 25.
3
27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.27-羟基胆固醇是一种内源性选择性雌激素受体调节剂。
Mol Endocrinol. 2008 Jan;22(1):65-77. doi: 10.1210/me.2007-0383. Epub 2007 Sep 13.
4
Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.循环 27-羟胆固醇与 CYP27A1、CYP7B1、LXR-β 和 ERβ 在乳腺癌组织中的表达:来自 EPIC-Heidelberg 队列的研究结果。
Breast Cancer Res. 2020 Feb 19;22(1):23. doi: 10.1186/s13058-020-1253-6.
5
Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.循环 27-羟胆固醇与乳腺癌风险:EPIC-Heidelberg 队列研究结果。
J Natl Cancer Inst. 2019 Apr 1;111(4):365-371. doi: 10.1093/jnci/djy115.
6
27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.27-羟胆固醇作用于髓样免疫细胞诱导 T 细胞功能障碍,促进乳腺癌进展。
Cancer Lett. 2020 Nov 28;493:266-283. doi: 10.1016/j.canlet.2020.08.020. Epub 2020 Aug 28.
7
27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling.27-羟基胆固醇:雌激素受体信号传导的潜在内源性调节因子。
Trends Pharmacol Sci. 2008 Oct;29(10):510-4. doi: 10.1016/j.tips.2008.07.003. Epub 2008 Aug 22.
8
Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.维生素 D 补充剂可降低试点乳腺癌试验中的血清 27-羟胆固醇。
Breast Cancer Res Treat. 2018 Feb;167(3):797-802. doi: 10.1007/s10549-017-4562-4. Epub 2017 Nov 7.
9
Obesity, cholesterol metabolism, and breast cancer pathogenesis.肥胖、胆固醇代谢与乳腺癌发病机制。
Cancer Res. 2014 Sep 15;74(18):4976-82. doi: 10.1158/0008-5472.CAN-14-1756. Epub 2014 Jul 24.
10
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.胆固醇代谢物27-羟基胆固醇通过作用于免疫细胞促进乳腺癌转移。
Nat Commun. 2017 Oct 11;8(1):864. doi: 10.1038/s41467-017-00910-z.

引用本文的文献

1
Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics.他汀类药物的使用与乳腺癌特异性死亡率和复发:一项系统评价和荟萃分析,包括永生时间偏倚和肿瘤特征的作用。
Br J Cancer. 2025 Jun 12. doi: 10.1038/s41416-025-03070-w.
2
Life's Essential 8 and Cardiovascular Disease in Breast Cancer Survivors.乳腺癌幸存者的生命基本八项与心血管疾病
Curr Cardiol Rep. 2025 Feb 15;27(1):55. doi: 10.1007/s11886-025-02216-9.
3
Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.

本文引用的文献

1
Metabolic syndrome and breast cancer prognosis.代谢综合征与乳腺癌预后
Breast Cancer Res Treat. 2014 Aug;147(1):159-65. doi: 10.1007/s10549-014-3076-6. Epub 2014 Aug 8.
2
A multilevel model of postmenopausal breast cancer incidence.绝经后乳腺癌发病率的多层次模型。
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2078-92. doi: 10.1158/1055-9965.EPI-14-0403. Epub 2014 Jul 13.
3
Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.通过激活核激素受体对转移性黑色素瘤进行广谱治疗性抑制。
循环 27-羟胆固醇、脂类和甾体激素与乳腺癌风险:多民族队列研究的巢式病例对照研究。
Breast Cancer Res. 2023 Aug 14;25(1):95. doi: 10.1186/s13058-023-01693-6.
4
The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk.肥胖与乳腺癌风险之间的分子和遗传相互作用。
Medicina (Kaunas). 2023 Jul 21;59(7):1338. doi: 10.3390/medicina59071338.
5
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.诊断后使用他汀类药物与乳腺癌特异性死亡率:基于人群的队列研究。
Breast Cancer Res Treat. 2023 May;199(1):195-206. doi: 10.1007/s10549-022-06815-w. Epub 2023 Mar 17.
6
Statin use in patients with hormone receptor-positive metastatic breast cancer treated with everolimus and exemestane.在接受依维莫司和依西美坦治疗的激素受体阳性转移性乳腺癌患者中使用他汀类药物。
Cancer Med. 2023 Mar;12(5):5461-5470. doi: 10.1002/cam4.5369. Epub 2022 Oct 19.
7
Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.岩藻黄质是治疗乳腺癌的一种潜在治疗剂。
Mar Drugs. 2022 May 30;20(6):370. doi: 10.3390/md20060370.
8
Association between serum lipids and breast cancer risk in premenopausal women: systematic review and meta-analysis.血清脂质与绝经前妇女乳腺癌风险的关联:系统评价和荟萃分析。
J Int Med Res. 2021 Nov;49(11):3000605211061033. doi: 10.1177/03000605211061033.
9
STARD4 promotes breast cancer cell malignancy.STARD4 促进乳腺癌细胞的恶性转化。
Oncol Rep. 2020 Dec;44(6):2487-2502. doi: 10.3892/or.2020.7802. Epub 2020 Oct 12.
10
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.使用他汀类药物与接受辅助芳香化酶抑制剂治疗的绝经后妇女乳腺癌复发的关系:一项丹麦基于人群的队列研究。
Breast Cancer Res Treat. 2020 Aug;183(1):153-160. doi: 10.1007/s10549-020-05749-5. Epub 2020 Jun 22.
Cell. 2014 Feb 27;156(5):986-1001. doi: 10.1016/j.cell.2014.01.038.
4
Prevalence of childhood and adult obesity in the United States, 2011-2012.美国儿童和成人肥胖率,2011-2012 年。
JAMA. 2014 Feb 26;311(8):806-14. doi: 10.1001/jama.2014.732.
5
Liver X receptor activation induces apoptosis of melanoma cell through caspase pathway.肝 X 受体激活通过半胱天冬酶途径诱导黑素瘤细胞凋亡。
Cancer Cell Int. 2014 Feb 25;14(1):16. doi: 10.1186/1475-2867-14-16.
6
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.脂代谢血清生物标志物与总体、乳腺癌和前列腺癌风险的前瞻性关联。
Eur J Epidemiol. 2014 Feb;29(2):119-32. doi: 10.1007/s10654-014-9884-5. Epub 2014 Feb 13.
7
27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.27-羟胆固醇将高胆固醇血症与乳腺癌病理生理学联系起来。
Science. 2013 Nov 29;342(6162):1094-8. doi: 10.1126/science.1241908.
8
27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.27-羟胆固醇促进细胞自主的、ER 阳性乳腺癌生长。
Cell Rep. 2013 Nov 14;5(3):637-45. doi: 10.1016/j.celrep.2013.10.006. Epub 2013 Nov 7.
9
Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients.正常对照组与乳腺癌患者血清脂质谱的比较
J Lab Physicians. 2013 Jan;5(1):38-41. doi: 10.4103/0974-2727.115934.
10
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.分子途径:脂肪组织炎症作为肥胖相关癌症的介质。
Clin Cancer Res. 2013 Nov 15;19(22):6074-83. doi: 10.1158/1078-0432.CCR-12-2603. Epub 2013 Aug 19.